Several pro-inflammatory cytokines like IL-1α previously demonstrated to participate in the inflammasome activation in β-cells and to participate in development of T2D was significantly reduced by anti-IL20 administration. This evidence concerns the gene IL1A and type 2 diabetes mellitus.